TFH lymphomas frequently harbor TET2 and DNMT3A mutations, and identical mutations have been identified in both the malignant T-cells and the myeloid component of patients, suggesting a common ancestral clone with subsequent divergent evolution [57]. The gene discussed is TET2; the disease is lymphoma.